{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:15:00Z","timestamp":1792073700109,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.numecd.2019.09.020","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T17:12:37Z","timestamp":1569517957000},"page":"265-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention"],"prefix":"10.1016","volume":"30","author":[{"given":"Na","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-fang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-da","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-lin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-5103","authenticated-orcid":false,"given":"Jin-qing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.numecd.2019.09.020_bib1","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1016\/S0021-9258(18)32663-2","article-title":"Human plasma lipoprotein (a)-Structural properties","volume":"258","author":"Gaubatz","year":"1983","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.numecd.2019.09.020_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(90)90177-K","article-title":"Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis","volume":"85","author":"Mbewu","year":"1990","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.numecd.2019.09.020_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1194\/jlr.R060582","article-title":"Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?","volume":"57","author":"Boffa","year":"2016","journal-title":"J Lipid Res"},{"issue":"22","key":"10.1016\/j.numecd.2019.09.020_bib4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.numecd.2019.09.020_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.numecd.2019.09.020_bib6","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.numecd.2019.09.020_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jacc.2014.03.061","article-title":"Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study","volume":"64","author":"Willeit","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.numecd.2019.09.020_bib8","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.numecd.2018.05.010","article-title":"Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus","volume":"28","author":"Zhang","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2019.09.020_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2017.03.021","article-title":"Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease","volume":"260","author":"Li","year":"2017","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.numecd.2019.09.020_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2014.05.052","article-title":"Prevalence and characteristics of TCFA and degree of coronary artery stenosis: an OCT, IVUS, and angiographic study","volume":"64","author":"Tian","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2019.09.020_bib11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2019.09.020_bib12","first-page":"219","article-title":"The SYNTAX score: an angiographic tool grading the complexity of CAD","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.numecd.2019.09.020_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIRCINTERVENTIONS.108.847137","article-title":"Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease","volume":"2","author":"Capodanno","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.numecd.2019.09.020_bib14","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"Par\u00e9","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.numecd.2019.09.020_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/eurheartj\/ehr350","article-title":"Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes","volume":"33","author":"Qi","year":"2012","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.numecd.2019.09.020_bib16","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1210\/jc.2016-1400","article-title":"Lipoprotein (a), the metabolic syndrome and vascular risk in Angiographied coronary patients","volume":"101","author":"Vonbank","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.numecd.2019.09.020_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.001696","article-title":"Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study","volume":"11","author":"Parish","year":"2018","journal-title":"Circ Genom Precis Med"},{"issue":"12","key":"10.1016\/j.numecd.2019.09.020_bib18","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.amjcard.2018.04.058","article-title":"Association of plasma lipoprotein(a) with long-term adverse events in patients with chronic kidney disease who underwent percutaneous coronary intervention","volume":"122","author":"Xu","year":"2018","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.numecd.2019.09.020_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MCA.0b013e3283587835","article-title":"SYNTAX score: an independent predictor of long-term cardiac mortality in patients with acute ST elevation myocardial infarction","volume":"23","author":"Yang","year":"2012","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.numecd.2019.09.020_bib20","first-page":"2506","article-title":"Third universal definition of myocardial infarction","author":"Taylor","year":"2012","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.numecd.2019.09.020_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2010.12.005","article-title":"Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic Research consortium","volume":"57","author":"Leon","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.numecd.2019.09.020_bib22","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.numecd.2019.09.020_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clinbiochem.2007.10.004","article-title":"Correlation between lipoprotein(a) serum concentration and severity of coronary artery stenosis in an Iranian population according to Gensini score","volume":"41","author":"Boroumand","year":"2008","journal-title":"Clin Biochem"},{"issue":"6","key":"10.1016\/j.numecd.2019.09.020_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jacc.2013.09.042","article-title":"Lipoprotein(a) for risk assessment in patients with established coronary artery disease","volume":"63","author":"O'Donoghue","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2019.09.020_bib25","first-page":"253","article-title":"Lipoprotein (a) as a marker for predicting the presence and severity of coronary artery disease in untreated Chinese patients undergoing coronary angiography","volume":"31","author":"Sun","year":"2018","journal-title":"Biomed Environ Sci"},{"issue":"32","key":"10.1016\/j.numecd.2019.09.020_bib26","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/eurheartj\/ehx166","article-title":"Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium","volume":"38","author":"Waldeyer","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.numecd.2019.09.020_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.CIR.86.2.475","article-title":"Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients","volume":"86","author":"Cressman","year":"1992","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.numecd.2019.09.020_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3109\/0886022X.2010.486097","article-title":"Lipoprotein-A and carotid intima media thickness as cardiovascular risk factors in patients of chronic kidney disease","volume":"32","author":"Aggarwal","year":"2010","journal-title":"Ren Fail"},{"issue":"14","key":"10.1016\/j.numecd.2019.09.020_bib29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","article-title":"Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors","volume":"293","author":"Shlipak","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.numecd.2019.09.020_bib30","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/ajkd.2000.17682","article-title":"Effect of apolipoprotein E polymorphismon serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients","volume":"36","author":"G\u00fcz","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.numecd.2019.09.020_bib31","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.numecd.2019.09.020_bib32","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1053\/euhj.1998.1043","article-title":"Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes","volume":"19","author":"Stubbs","year":"1998","journal-title":"Eur Heart J"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947531930359X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947531930359X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:11:37Z","timestamp":1760544697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947531930359X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S093947531930359X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2019.09.020","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2019.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}